symbol-JSP

JSP JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED

JSP
JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED
1.97
+0.01 (+0.51%)
High2.00
Low1.96
Total Vol66,000
Total Val(K)131.00
Description
Develop, manufacture, and sell modern medicine, traditional medicine, herbal product, dietary supplement, medical supply, and cleaning alcohol under client`s trademark and the Company`s trademark.

Overview


  • SymbolJSP
  • Market Cap (M.Bath)934.91
  • IPO Date2 Nov 2021
  • IPO Price7.00 @Par Value 0.50 Baht
  • CEOMr. THONGCHAI THAVICHACHART
  • Employees-
  • IndustryCONSUMP-M
  • Sector-
  • IndexMAI
  • SET ESG Ratings-

สรุปภาพรวมตลาด

Period
Ex-Date
Record Date
Shareholders List Date
Dividend Payment Date
Type
Dividend (Baht/Share)
Unit
Financial Period
Dividend From
28 Apr 2026
-
29 Apr 2026
15 May 2026
Cash Dividend
0.05 Baht
Baht
01 Jan 2025 - 31 Dec 2025
Net profit
26 Aug 2025
-
27 Aug 2025
12 Sep 2025
Cash Dividend
0.05 Baht
Baht
01 Jan 2025 - 30 Jun 2025
Net profit
28 Aug 2024
-
29 Aug 2024
12 Sep 2024
Cash Dividend
0.03 Baht
Baht
01 Jan 2024 - 30 Jun 2024
Net profit
19 Apr 2022
-
20 Apr 2022
29 Apr 2022
Cash Dividend
0.01 Baht
Baht
01 Jan 2021 - 31 Dec 2021
Net profit
Note
Approximate Date Shows ex-rights and ex-dividend marks and entitlements over the past 5 years

Key Issues

Upcoming Event

Relate Stock Industry

Check out other big names from the same Industry JSP

symbol-https://s3.efinancethai.com/symbols-logo/JSP.pngJSP
efin Focus Metrics
Quarter 4/2025
Z-Score
2.16
3.11
3.32
Monitor C-Score
0.00
0.00
0.00
ICR
7.87
4.97
16.18
DSCR
1.10
0.00
0.00
EV/EBITDA
7.55
136,600.34
89,302.55
FCF Yield
47.31
0.00
0.00
FCF/Net Income
9.45
0.00
0.00
Net Debt/EBITDA
1.78
0.00
0.00
ROIC
4.98
3.23
7.22
Valuation Metrics
Last Price
1.97
1.70
1.77
P/E
13.57
38.00
12.46
P/BV
0.99
0.82
0.76
Dividend Yield
1.66
11.61
0.00
Financial Strength
D/E
0.58
0.36
0.21
Current Ratio
1.39
3.95
4.28
Net Profit Margin
4.33
1.75
10.12
ROE/ROA
0.94
0.70
1.69
Growth Metrics
Revenue Growth YoY
14.50
32.55
-7.16
Revenue Growth 3Y
94.07
58.57
78.75
Revenue Growth 3Y CAGR
24.73
16.61
21.36
Revenue per Share
0.00
0.00
0.00
EPS Growth
-148.19
-33.33
181.03
EBITDA Growth
305.78
-49.53
-191.38
5Y CAGR Total Return
0.00
0.00
-34.03
Market Cap (M.Bath)
901.69
1,140.00
729.67
Average Volume
1,086.00
4,963.89
25,086.10

efin Focus Metrics

Quarter 4/2025
Z-Score
Monitor C-Score
ICR
DSCR
EV/EBITDA
FCF Yield
FCF/Net Income
Net Debt/EBITDA
ROIC
Z-Score
xxx
xxx
xxx
Monitor C-Score
xxx
xxx
xxx
ICR
xxx
xxx
xxx
DSCR
xxx
xxx
xxx
EV/EBITDA
xxx
xxx
xxx
FCF Yield
xxx
xxx
xxx
FCF/Net Income
xxx
xxx
xxx
Net Debt/EBITDA
xxx
xxx
xxx
ROIC
xxx
xxx
xxx

Valuation Metrics

Last Price
1.97
1.70
1.77
P/E
13.57
38.00
12.46
P/BV
0.99
0.82
0.76
Dividend Yield
1.66
11.61
0.00

Financial Strength

D/E
0.58
0.36
0.21
Current Ratio
1.39
3.95
4.28
Net Profit Margin
4.33
1.75
10.12
ROE/ROA
0.94
0.70
1.69

Growth Metrics

Revenue Growth YoY
14.50
32.55
-7.16
Revenue Growth 3Y
94.07
58.57
78.75
Revenue Growth 3Y CAGR
24.73
16.61
21.36
Revenue per Share
0.00
0.00
0.00
EPS Growth
-148.19
-33.33
181.03
EBITDA Growth
305.78
-49.53
-191.38
5Y CAGR Total Return
0.00
0.00
-34.03
Market Cap (M.Bath)
901.69
1,140.00
729.67
Average Volume
1,086.00
4,963.89
25,086.10
Note
  • Calculated using adjusted prices.
  • Data is shown and calculated based on consolidated financial statements, presented as year-to-date quarterly figures. (If consolidated statements are unavailable, company-only statements are used.)
  • Financial data is updated quarterly within 7 business days after new statements are released.
  • Financial statement data reflects what listed companies submit for each period. Users should review the full financial statements for details, as some companies may revise comparative figures in the latest full version.
  • The list of companies included in the SETESG Index is announced together with other indices, based on the latest SET ESG Ratings results. Source: www.set.or.th (Copyright @ The Stock Exchange of Thailand).